Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

ANI Pharma Inc (ANIP)

ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,770,929
  • Shares Outstanding, K 22,414
  • Annual Sales, $ 883,370 K
  • Annual Income, $ 78,340 K
  • EBIT $ 203 M
  • EBITDA $ 294 M
  • 60-Month Beta 0.44
  • Price/Sales 2.02
  • Price/Cash Flow 8.00
  • Price/Book 3.31

Options Overview Details

View History
  • Implied Volatility 53.13% (+0.12%)
  • Historical Volatility 34.35%
  • IV Percentile 89%
  • IV Rank 50.02%
  • IV High 73.85% on 07/24/25
  • IV Low 32.40% on 09/22/25
  • Expected Move (DTE 8) 8.13 (10.15%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 114
  • Put/Call OI Ratio 1.65
  • Today's Open Interest 6,750
  • Open Int (30-Day) 6,432
  • Expected Range 72.01 to 88.27

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $1.08
  • Number of Estimates 4
  • High Estimate $1.54
  • Low Estimate $0.77
  • Prior Year $1.37
  • Growth Rate Est. (year over year) -21.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
70.15 +14.24%
on 03/13/26
82.08 -2.36%
on 04/08/26
+5.33 (+7.12%)
since 03/09/26
3-Month
70.15 +14.24%
on 03/13/26
87.07 -7.96%
on 01/16/26
+3.86 (+5.06%)
since 01/09/26
52-Week
56.71 +41.32%
on 05/23/25
99.50 -19.46%
on 09/10/25
+14.13 (+21.41%)
since 04/09/25

Most Recent Stories

More News
ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet

PRINCETON, N.J., April 08, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug Administration...

ANIP : 80.14 (+1.43%)
Artivion, ANI Pharmaceuticals, and Privia Health Shares Are Soaring, What You Need To Know

Artivion, ANI Pharmaceuticals, and Privia Health Shares Are Soaring, What You Need To Know

PRVA : 22.71 (unch)
ANIP : 80.14 (+1.43%)
AORT : 36.51 (+1.25%)
ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology

PRINCETON, N.J., April 07, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced publication of the results from the NEW DAY clinical trial involving...

ANIP : 80.14 (+1.43%)
3 Russell 2000 Stocks We Steer Clear Of

3 Russell 2000 Stocks We Steer Clear Of

SMPL : 11.80 (-18.11%)
OBK : 45.37 (+3.61%)
ANIP : 80.14 (+1.43%)
3 Reasons ANIP is Risky and 1 Stock to Buy Instead

3 Reasons ANIP is Risky and 1 Stock to Buy Instead

ANIP : 80.14 (+1.43%)
2 of Wall Street’s Favorite Stocks Worth Your Attention and 1 We Question

2 of Wall Street’s Favorite Stocks Worth Your Attention and 1 We Question

ADI : 351.36 (+1.49%)
MIR : 19.11 (-5.11%)
ANIP : 80.14 (+1.43%)
3 Profitable Stocks That Concern Us

3 Profitable Stocks That Concern Us

BK : 128.58 (+0.50%)
ANIP : 80.14 (+1.43%)
QTWO : 46.04 (-4.52%)
Generic Pharmaceuticals Q4 Earnings: ANI Pharmaceuticals (NASDAQ:ANIP) Simply the Best

Generic Pharmaceuticals Q4 Earnings: ANI Pharmaceuticals (NASDAQ:ANIP) Simply the Best

ANIP : 80.14 (+1.43%)
Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need To Know

Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need To Know

SOLV : 66.18 (+1.43%)
GH : 87.17 (-6.11%)
ALHC : 21.38 (+0.33%)
ANIP : 80.14 (+1.43%)
CLOV : 1.9100 (-0.52%)
ANI: Q4 Earnings Snapshot

ANI: Q4 Earnings Snapshot

ANIP : 80.14 (+1.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

ANI Pharmaceuticals, Inc. is a specialty pharmaceutical company. It engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The company offers liquid, powder, oral solid dose, cough/cold products, antacids, laxatives, stomach remedies as well as hydrocortisone...

See More

Key Turning Points

3rd Resistance Point 83.44
2nd Resistance Point 82.11
1st Resistance Point 81.13
Last Price 80.14
1st Support Level 78.82
2nd Support Level 77.49
3rd Support Level 76.51

See More

52-Week High 99.50
Fibonacci 61.8% 83.15
Last Price 80.14
Fibonacci 50% 78.10
Fibonacci 38.2% 73.06
52-Week Low 56.71

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.